MARKET

MNKD

MNKD

Mannkind
NASDAQ
3.710
-0.040
-1.07%
After Hours: 3.740 +0.03 +0.81% 19:34 12/05 EST
OPEN
3.720
PREV CLOSE
3.750
HIGH
3.790
LOW
3.640
VOLUME
2.57M
TURNOVER
0
52 WEEK HIGH
5.75
52 WEEK LOW
3.375
MARKET CAP
1.00B
P/E (TTM)
-30.9942
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at MNKD last week (1127-1201)?
Weekly Report · 2d ago
Weekly Report: what happened at MNKD last week (1120-1124)?
Weekly Report · 11/27 10:39
MannKind: Continues To Kick The Can Down The Road For Investors
Mannkind needs to decide if afrezza will be a reliable source of revenue or a drag on future revenues. United has been an unreliable partner for future use of mannkind's technology. Latest revenue results are not favorable for mannkind nor united. Mannkind corporation.
Seeking Alpha · 11/25 08:20
Weekly Report: what happened at MNKD last week (1113-1117)?
Weekly Report · 11/20 10:37
After Hours Most Active for Nov 13, 2023 : ATUS, NEM, PLTR, KO, DFS, MTCH, PFE, VGSH, INTC, JD, MNKD, AAPL
NASDAQ · 11/13 21:29
Weekly Report: what happened at MNKD last week (1106-1110)?
Weekly Report · 11/13 10:32
MNKD, QDEL and GDRX are among after hour movers
On the move: mnkd, qdel and gdrx are among after hour movers. Stoneco, stne, holx and cardlytics are among the gainers. Cjet, uctt and hcp are among those losers.
Seeking Alpha · 11/10 22:00
Strong Q3 Results and Promising Clinical Progress: A Buy Rating for MannKind
TipRanks · 11/10 11:31
More
About MNKD
MannKind Corporation is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. The Company's technologies, Technosphere dry-powder formulations and Dreamboat inhalation devices offer convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation. The Company's products are Afrezza (insulin human) Inhalation Powder, and V-Go wearable insulin delivery device. Afrezza (insulin human) Inhalation Powder is an inhaled insulin indicated to improve glycemic control in adults with diabetes. Afrezza consists of a dry powder formulation of human insulin delivered from a small portable inhaler. V-Go wearable insulin delivery device provides continuous subcutaneous infusion of insulin in adults that require insulin.

Webull offers MannKind Corp stock information, including NASDAQ: MNKD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MNKD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MNKD stock methods without spending real money on the virtual paper trading platform.